Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.

Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial. Thromb Haemost. 2019 Mar; 119(3):461-466.

View in: PubMed

subject areas

Adult
Aged
Anticoagulants
Double-Blind Method
Drug Administration Schedule
Enoxaparin
Factor Xa Inhibitors
Female
Hemorrhage
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors
Pyrazoles
Pyridones
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Venous Thromboembolism
Warfarin

authors with profiles

Gary E Raskob